Business Context and Reporting Period
Company: Henry Schein, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 29, 2009
Event: Entry into a Material Definitive Agreement (Omnibus Agreement) to combine Henry Schein's U.S. animal health business with Butler Animal Health Supply, LLC (BAHS).
Key Financial Metrics and Transaction Structure
- Equity Acquisition: Henry Schein will pay approximately $55 million in cash to acquire a 50.1% equity interest in Butler Holding (indirectly through Winslow Acquisition Company).
- Asset Contribution: The Company will contribute assets and liabilities related to its U.S. animal health business to BAHS.
- Debt Impact: As part of a recapitalization at closing, BAHS will incur approximately $300 million in debt, which will be reflected on Henry Schein's consolidated balance sheet.
- Cash Proceeds to Sellers: Owners of BAHS will receive a total of approximately $155 million in cash from the transaction and recapitalization.
- Put Rights Liability:
- Oak Hill Capital Partners: Maximum payment caps of $125 million (Year 1), $137.5 million (Year 2), and $150 million (Year 3+).
- Burns Veterinary Supply: Rights exercisable after the fifth anniversary to sell up to 20% of its interest.
- Aggregate Cap: If Oak Hill retains interests when Burns rights begin, the aggregate put amount to both parties in any year will not exceed $150 million.
Material Changes and Transaction Conditions
This filing reports a material change in the Company's capital structure and business operations through the formation of a joint venture. The transaction is subject to closing conditions, including the refinancing of BAHS's existing credit facility. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired.
Outlook, Risks, and Contingencies
- Contingent Liabilities: The Company has entered into Put Rights Agreements with Oak Hill and Burns, creating potential future cash outflows if these parties exercise their rights to sell their ownership interests back to Henry Schein.
- Debt Assumption: The immediate impact includes the consolidation of approximately $300 million in new debt on the Company's balance sheet.
- Regulatory Disclosure: The filing includes a Regulation FD disclosure referencing a press release issued on November 30, 2009, announcing the combination to form the leading supplier to U.S. companion animal veterinarians.
- Disclaimer: The filing explicitly states that representations and warranties in the agreement are for the benefit of the parties and should not be relied upon by investors as characterizations of actual facts.
Key Facts for Investor Verification
- Verify the exact timing of the closing and the immediate impact on the consolidated balance sheet regarding the $300 million debt assumption.
- Review the terms of the Put Rights Agreements (Exhibit 10.1) to understand the valuation methodology for potential future buybacks.
- Confirm the status of the BAHS credit facility refinancing, which is a condition precedent to closing.
- Assess the strategic rationale for contributing U.S. animal health assets versus retaining them, as detailed in the press release (Exhibit 99.1).